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Abstract
Background: Mesenchymal stem cells (MSCs) are widely used 
to treat various diseases, however, their proliferative potential 
reduces after a number of passages. It has been shown that some 
probiotics such as Bifidobacterium bifidum (B. bifidum) affect 
the proliferation of various cell lineages. The present study 
aimed to investigate the effect of B. bifidum on the proliferation 
of rat bone marrow stromal cells (rBMSCs) and to develop a 
method for compensating their proliferation reduction after 
some passages. 
Methods: The present experimental study was conducted 
at Tehran University of Medical Sciences, Tehran, Iran, in 
2017. The stromal cells were isolated from rBMSCs and their 
mesenchymal properties were confirmed by osteogenic and 
adipogenic differentiation media and staining. B. bifidum was 
cultured and the B. bifidum supernatant (BS) and bacterial cell 
mass (BCM) were extracted. The rBMSCs were treated with 
different concentrations of BS and BCM. The MTT assay was 
performed to measure the number of viable cells in the culture. 
Cell proliferation was analyzed using the paired-sample t test.
Results: Cell proliferation increased as the concentration of 
bacteria was increased logarithmically (0, 0.1, 0.3, 0.9, 3, 9, 30 
μL/mL). In comparison with BS, cells treated with BCM showed 
increased cell proliferation at lower concentrations. This effect 
was caused by removing the “de Man, Rogosa, and Sharpe” 
(MRS) broth medium from the BCM culture. The optimal 
concentration of bacteria with the most significant effect on 
rBMSCs proliferation was determined.
Conclusion: A significant increase in the proliferation of 
stromal cells was observed; confirming the stimulatory potential 
of probiotics (B. bifidum) on various cells. The use of products 
containing probiotic bacteria can increase the proliferation 
potential of BMSCs. 
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What’s Known
• Lactobacillus acidophilus 
supernatant can promote angiogenesis 
and increase the proliferation potential of 
some cell lineages, such as macrophages 
and bone marrow stromal cells.
• MRS broth media can interfere 
with the treatment of bacterial agents.
What’s New
• The effect of probiotics on the cell 
proliferation of individual low-proliferative 
stem cells has been confirmed. Common 
characteristics among probiotics have 
been demonstrated. 
• The effect of both the supernatant 
and bacterial cell mass was investigated. 
The use of bacterial cell mass is shown 




Today, there has been a growing consumption of products 
containing probiotic bacteria to treat various diseases.1 This 
group of bacteria has several benefits such as modulating 
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gastrointestinal microorganisms.2 Studies have 
shown the health benefits of specific probiotic 
strains of Lactobacillus, Bifidobacterium, 
Saccharomyces, Enterococcus, Streptococcus, 
Pediococcus, Leuconostoc, Bacillus, Escherichia 
coli.3 Although the activating mechanism of 
many probiotics has been identified, there 
are ongoing research studies to understand 
other mechanisms and their effects on various 
diseases. For instance, the effect of probiotics on 
diarrhea,4 cholesterol absorption,5 and lactose 
sensitivity6 has been demonstrated.
Several studies have addressed the effect of 
probiotics on diseases such as immune system 
disorders and cancer. A previous study has 
shown that oral administration of probiotics could 
be a mitogen for lymphocytes proliferation and 
increase serum levels of IgG, IgM, and secretory 
IgA.7 Studies have been conducted to investigate 
the effect of probiotics on the proliferation 
of various cell lineages. Some studies have 
shown the potential of probiotics on reducing 
the proliferation of cancer cells (especially 
gastrointestinal carcinoma),8, 9 and some others 
have used probiotic agents as adjuvants to control 
gastrointestinal cancer.10 A previous study showed 
that the supernatants of Lactobacillus acidophilus 
(LS) stimulated the proliferation of macrophages 
and lymphocytes by increasing chemotaxis and 
angiogenesis properties.11 The effect of LS on 
embryonic stem cells and on the proliferation of 
rat bone marrow stromal cells (rBMSCs) has also 
been demonstrated.12, 13 Additionally, the role of 
probiotics in cell differentiation has been studied.14 
Stem cells, particularly mesenchymal stem 
cells (MSCs), are widely used to treat various 
diseases such as cancer. Recent advancement 
in stem cell transplantation has resulted in 
increased effectiveness of such treatments.15, 16 
However, one of the main limitations of MSCs 
is the reduction of their proliferative potential 
after numerous passages whereby cells tend 
to differentiate. Consequently, it is important to 
find methods to increase the proliferation rate of 
these cells.17 It has been shown that Lactobacillus 
stimulates the proliferation of macrophages 
and lymphocytes, and it has some common 
metabolic properties with Bifidobacterium.18-20 
Hence, the present study aimed to investigate 
the effect of Bifidobacterium bifidum (B. bifidum) 
on rBMSCs and to develop a method for 
compensating for their proliferation reduction 
after some passages. 
Materials and Methods
The present experimental study was conducted 
at Tehran University of Medical Sciences, 
Tehran, Iran.
Preparation of Bacterial Supernatant and 
Extract
B. bifidum strain (ATCC: 29521) was 
obtained from the Iran Research Organization 
for Science and Technology (IROST), Tehran, 
Iran, in 2017. The bacteria were cultured in 
MRS broth (pH value 5.5, Millipore-110661) with 
0.05% L-cysteine (Sigma, 24850236) at 37 °C 
for 48 hours under microaerophilic conditions.11, 
21 The suspension was centrifuged three times 
at 10,000 ×g at 4 ˚C until the bacterial count 
reached 2x108 CFU, using the pour plate 
method.22 The supernatant was separated and 
filtered using a 0.2 µm microfilter. Then, the B. 
bifidum supernatant (BS) was frozen and stored 
for later use. To isolate the bacterial extract, 
the sediment mass was harvested after each 
centrifugation.12
Isolation of Rat Bone Marrow Stromal Cells
A male rat (6-8 weeks old, weighing 
300 grams) was obtained from the Pasteur 
Institute, Tehran, Iran. In accordance with the 
University’s code of ethics (number: IR.TUMS.
REC.1394.533) the rat was sacrificed by CO2 
asphyxiation. The tibia was dissected under 
sterile conditions and the surrounding muscle 
tissue was completely removed. The tibia 
was cut at both ends and the bone marrow 
stromal tissue was flushed out with a mixture of 
Dulbecco’s modified eagle’s medium (DMEM), 
2 mM Glutamax, 1 mM L-glutamine, 10% fetal 
bovine serum (FBS), 1% penicillin/streptomycin, 
nystatin and amphotericin B, and 1% non-
essential amino acids (all from Gibco, Carlsbad, 
CA). Finally, the cells were filtered through a 
70 mm diameter filter (Hawach Scientific Co., 
China) to remove debris.13
Primary Stromal Cell Culture
Cell viability was determined using trypan 
blue dye (Merck, Millipore, 23850, Germany).23 
A Petri dish containing the complete culture 
medium, as mentioned above, was used to seed 
25×106 cells and was subsequently incubated 
under standard conditions with 5% CO2 at 
37 °C for 3 hours. Then, the unattached cells 
were removed and the medium was replaced 
with the fresh culture medium. After 8 hours, 
the medium was replaced again with 10 mL 
of fresh culture medium. This process was 
repeated every 8 hours for 72 hours, after which 
the remaining attached cells were washed with 
phosphate-buffered saline (PAA Laboratories 
GmbH, Austria); the medium was replaced 
every 3 days. After 4 weeks, when the culture 
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reached about 80% confluency, it was incubated 
for 2 minutes with 25% trypsin in 1 mM EDTA 
(L11-001, PAA Laboratories Inc, Austria). After 
trypsin neutralization, the cells were seeded in 
25 cm2 flasks.24
Cell Differentiation into Osteogenic and 
Adipogenic Lineages
A total of 5x104 cells were seeded in 6-well 
plates containing DMEM, 15% FBS, and 1% 
penicillin/streptomycin. The cultures were 
divided into three groups. The culture medium 
of the first group included rBMSCs without any 
B. bifidum contents. The second group included 
rBMSCs in the differentiation medium together 
with BS and the third group with B. bifidum 
bacterial cell mass (BCM). These cultures were 
incubated under standard conditions with 5% 
CO2 at 37 °C for 7 days. The cells were then 
cultured in an osteogenic or an adipogenic 
differentiation defined medium and incubated for 
21 days during which the medium was replaced 
every 3 days.25
Each milliliter of the osteogenic culture 
medium composed of DMEM, 50 mg/mL ascorbic 
acid 2-phosphate, 10 nM dexamethasone, and 
10 nM β-glycerol phosphate, all producted by 
Sigma Aldrich, US. Finally, the cells were fixed 
for 10 minutes in 10% formalin, stained with 
Alizarin red for 15 minutes at room temperature, 
and observed under a light microscope 
(Olympus, Germany).26 Similarly, each milliliter 
of adipogenic culture medium composed of 
DMEM supplemented with 15% FBS, 50 mg/
mL indomethacin, and 100 M dexamethasone. 
To determine adipocytes differentiation, the cells 
were stained with 0.5% Oil red-O for 15 minutes 
and then observed under a light microscope.27
Cell Proliferation Assay
The cell viability was determined 
using the [3-(4,5 dimethylthiazol-2-yl)-1,5 
diphenyltetrazolium bromide] MTT colorimetric 
assay. The principle of the MTT assay is the 
ability of the living cells to convert tetrazulium to 
formazan.28 In brief, 5×103 cells were seeded in 
a 96-well microplate. The cells were then treated 
for 14 days with the medium from each of the 
two groups containing BS or BCM in different 
concentrations (0, 0.1, 0.3, 0.9, 3, 9, and 30 
μL/mL of supplemented DMEM).13 During this 
period, the medium was replaced every 3 days. 
Besides, a control group (standard) was added, 
which included the cells with culture medium 
without BS and BCM.
The medium was replaced with 15% MTT 
solution (Atocel, Austria) in PBS (5 mg/ml) and 
incubated at 37 °C for 2 hours. The solution in 
each well was replaced with DMSO and shaken 
in a dark chamber for 15 minutes. Finally, the 
optical density for each well was measured using 
a plate reader at the wavelength of 570 nm and 
a reference wavelength of 630 nm. The number 
of cells was determined using a standard curve. 
The tests were repeated six times for each 
sample (n=6).
Statistical Analyses
Distribution of the data was evaluated using 
the Kolmogorov-Smirnov test (one-sample and 
pair-sample tests). The data were expressed 
as mean±SD and analyzed using the paired-
sample t test. P<0.05 was considered statistically 
significant. The SigmaPlot software (version 
12.0) was used for the graphical presentation of 
the data. 
Results
Cell Differentiation into Osteogenic and 
Adipogenic Lineages
After the preparation of the primary cell 
culture, the cells were used in the second 
passage (figure 1a). The rBMSCs were cultured 
in osteogenic and adipogenic media, after 
which the cells differentiated into osteoblasts 
and adipocytes. Figure 1 (b, c) shows the 
cells subjected to osteogenic differentiation 
Figure 1: (a) The rat bone marrow stromal cells in the second passage (400× by inverted microscopic system). (b) The rat bone 
marrow stromal cells after 14 days in osteogenic media; stained with Alizarin red. (c) The rat bone marrow stromal cells after 14 
days in adipogenic media; stained with Oil red-O. 
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for 14 days and then stained with Alizarin red. 
Calcium deposition was detected, indicating 
their differentiation potential (figure 1b). The 
rBMSCs cells cultured in an adipogenic 
differentiation medium (stained by Oil red-O) 
differentiated into adipocytes (figure 1c). This 
differentiation was considered a key feature of 
the rBMSCs, especially the MSCs. After 14 days 
of rBMSCs treatment with BS and BCM, using 
the exact same protocol, the staining process 
was performed with Alizarin red and Oil red-O. 
Figure 2 shows a comparison between the test 
sample and the negative control.
Cell Proliferation Assay
The viability of the cells was determined using 
the MTT assay after treating the rBMSCs with 
different quantities of BS or BCM. The optical 
density for each well, measured with a plate 
reader, was converted to the number of cells 
using the standard curve (tables 1 and 2). In 
parallel, the viability of the cells was determined 
in cells treated with MRS broth medium with 
similar concentrations as BS and BCM. The 
results between the groups were analyzed and 
compared using the paired-sample t test. The 
results showed that changes in cell proliferation 
in the MRS broth medium were less than 
changes in BS and BCM. The cell proliferation 
at low concentrations of the MRS broth (0.1, 
0.3, and 0.9 μL/mL) was similar to the control 
group. However, cell viability reduced at higher 
concentrations.
The results of the MTT assay showed 
Figure 2: (a) The rat bone marrow stromal cells after 14 days of treatment with Bifidobacterium bifidum supernatant; stained with 
Alizarin red. (b) The rat bone marrow stromal cells after 14 days of treatment with Bifidobacterium bifidum supernatant; stained 
with Oil red-O (400× using the inverted microscopic system).
Table 1: The number of cells treated with Bifidobacterium bifidum supernatant in different concentrations
Bacterial supernatant 
concentration (μL/mL)
The number of cells mean±SD P value
0.1 12686 12309 12792 12786 12260 12680 12585.5±238.44 0.283
0.3 12663 12483 12852 12511 12917 12711 12689.5±175.40 0.271
0.9 12715 12905 12823 12688 12694 12992 12802.83±125.99 0.235
3.0 13336 13557 13244 13501 13218 13423 13379.83±137.47 0.186
9.0 14274 14841 14564 14510 14331 14404 14487.33±204.14 0.011
30.0 13780 14109 13914 14278 13899 13662 13940.33±222.73 0.046
Table 2: The number of cells treated with bacterial cell mass in different concentrations
Bacterial cell mass 
concentration (μL/mL)
The number of cells mean±SD P value
0.1 12686 12309 12792 12786 12260 12680 12585.5±238.44 0.283
0.3 12761 12585 12957 12611 12812 12611 12722.83±147.14 0.266
0.9 13105 12905 12823 12288 12914 12992 13004.5±285.65 0.249
3.0 13801 13757 14244 13901 14218 13723 13940.67±232.85 0.040
9.0 14450 14731 14812 14596 14646 14804 14673.17±138.73 0.036
30.0 12780 13109 12914 13278 12899 12662 12940.33±222.73 0.241
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that treatment with BS and BCM induced the 
proliferation of BMSCs (figures 3 and 4). An 
increase in cell proliferation with the BS treatment 
started at 0.9 μL/mL concentration and reached 
its peak at 9 μL/mL. It was also observed that cell 
proliferation reduced at higher concentrations 
(30 μL/mL). An increase in BMSCs proliferation 
with BCM treatment started at 0.3 μL/mL 
concentration and peaked at 9 μL/mL. The 
outcomes of the treatment were compared with 
the results of the negative control group. 
The results obtained from the treatment 
of rBMSCs with B.bifidum showed that the 
maximum cell proliferation was at 9 μL/mL 
concentration. At this concentration, there 
was a significant increase in cells treated 
with BS (P=0.011) and BCM (P=0.036). It was 
observed that both the BS and BCM had the 
maximum effect at this concentration (tables 1 
and 2). Comparing each concentration with the 
negative control showed that the highest level of 
significance was at 9 μL/mL concentration, but 
the effect in other quantities of BS or BCM was 
also significant. For instance, treatment with 
BS at 30 μL/mL concentration (P=0.046) and 
treatment with BCM at 3 μL/mL concentration 
(P=0.040).
Discussion
The results showed a significant increase 
in the proliferation of stromal cells, which 
confirmed the stimulatory potential of probiotics 
(Lactobacillus13 and Bifidobacterium) on various 
cells. Several studies have shown the effect 
of probiotics in limiting the proliferation of 
neoplastic cells, especially in gastrointestinal 
tract cancers.29 On the other hand, some other 
studies have confirmed the anti-apoptotic role of 
Bifidobacterium in the intestinal epithelial cells.30 
In contrast with the results of a previous study 
on the effects of Lactobacillus,13 we found a 
significant increase in cell proliferation with B. 
bifidum at 9 μL/mL concentration. The increase 
in cell proliferation in the BCM culture started at 
lower concentrations (0.3 μL/mL) while the onset 
of cell proliferation in the BS culture was at 0.9 
μL/mL. The results also showed a decrease in 
cell proliferation in the BCM and BS cultures 
at higher concentrations (30 μL/mL); indicating 
increased effectiveness at lower concentrations.
To understand the mechanism responsible 
for increased cell proliferation, we used BCM 
as a supernatant while previous studies used 
probiotics.13, 31-33 In addition, B. bifidum was used 
in the present study to measure cell proliferation 
whereas previous studies used Lactobacillus. 
Nonetheless, the results are comparable since 
both bacteria exhibited similar cell proliferation 
characteristics. It was observed that both B. bifidum 
and Lactobacillus had the potential to increase 
stromal cell proliferation. Although Lactobacillus 
Figure 3: The effect of the logarithmic concentrations of 
Bifidobacterium bifidum supernatant on rat bone marrow 
stromal cells. The MTT assay showed that the highest 
proliferation occurred in 9 µL/mL concentration. The control 
group included cells with standard culture medium without 
Bifidobacterium bifidum supernatant and bacterial cell mass 
as a negative control.
Figure 4: The effect of bacterial cell mass on rat bone 
marrow stromal cells in different logarithmic concentrations 
(MTT assay). The control group included cells and standard 
culture medium without Bifidobacterium bifidum supernatant 
and bacterial cell mass as a negative control.
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was more effective at lower concentrations, the 
increase in both bacteria was somewhat similar. 
Therefore, we believe that these bacteria share 
common characteristics. Further research to 
confirm this finding is recommended. 
The MRS broth was a suitable medium 
for the cultivation of Lactobacillus and 
Bifidobacterium.21 However, similar to a previous 
study,13 we observed an inhibitory effect on cell 
viability at high concentrations of MRS broth. 
Since the amount of MRS broth medium reached 
the lowest level in the BCM group, the inhibitory 
effect of the culture medium was reduced. If 
the bacterial culture medium is removed, it 
is anticipated that cell proliferation would be 
slightly higher than BCM. Therefore, using an 
alternative method (freeze-drying) may reduce 
the inhibitory effects of the bacterial medium. 
By comparing the results from cell treatment 
with BS and BCM, the most effective inhibitory 
role of the bacterial medium was in the use of 
supernatant. Note that during the process of 
BCM preparation, a maximum amount of MRS 
broth media was eliminated by centrifugation. 
A previous study on Lactobacillus indicated 
that the substances secreted in the supernatant 
had primarily overcome the inhibitory effect 
of MRS broth.13 The results of the present 
study suggest that B. bifidum can also partially 
overcome the inhibitory effect of the bacterial 
medium. In addition, there was significant cell 
proliferation in some concentrations of BS. 
Therefore, it is most likely that there were common 
substances in Lactobacillus and Bifidobacterium 
supernatants that stimulated the proliferation 
of cells in multiple passages. In the absence 
of these substances, cell proliferation gradually 
decreased after some passages.34 These findings 
confirm the presence of substances secreted 
by some probiotic bacteria that can be used as 
stimulants for the proliferation of stromal cells. 
Therefore, the use of B. bifidum supernatant in 
an optimum concentration can be beneficial and 
an effective factor in the proliferation of cells 
such as rBMSCs. 
The main limitation of the present study 
was the fact that the MRS medium in high 
concentrations (>9 μL/mL) influenced cell 
proliferation. The complexity of the secreted 
substances in the bacterial supernatant was 
another constraint on the study. The use of 
magnetic-activated cell sorting (MACS) is 
recommended to isolate some specific cells 
such as MSCs. 
Conclusion
The use of B. bifidum is a low-cost and accessible 
method to increase the proliferation potential 
of BMSCs. B. bifidum can be easily cultivated, 
propagated, and is a suitable culture medium. 
Further studies are required to complement 
our initial findings and to provide detailed 
information on the effective substances causing 
cell proliferation by probiotic bacteria. 
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